Home / Amitriptyline / Canada
CA ATC N06AA09 · updated 2 Nov 2026
Amitriptyline shortage in Canada
Is there an Amitriptyline shortage in Canada?
Yes. As of 2 Nov 2026, 29 Amitriptyline products are reported short in Canada, the first since 20 Apr 2011. No return date has been given. Main reason: manufacturing problem.
Also short in Germany, Ireland, Norway, Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | BIO-AMITRIPTYLINE (100) | BIOMED PHARMA | 20 Apr 2011 | not given | Other Other (Please describe in comments) |
| CA | BIO-AMITRIPTYLINE (500) | BIOMED PHARMA | 20 Apr 2011 | not given | Other Other (Please describe in comments) |
| CA | BIO-AMITRIPTYLINE (500) | BIOMED PHARMA | 20 Apr 2011 | not given | Other Other (Please describe in comments) |
| CA | LEVATE (100) | BIOMED PHARMA | 23 Oct 2014 | not given | Other Other (Please describe in comments) |
| CA | LEVATE (100) | BIOMED PHARMA | 23 Oct 2014 | not given | Other Other (Please describe in comments) |
| CA | LEVATE (100) | BIOMED PHARMA | 23 Oct 2014 | not given | Other Other (Please describe in comments) |
| CA | LEVATE (100) | BIOMED PHARMA | 23 Oct 2014 | not given | Other Other (Please describe in comments) |
| CA | JAMP-AMITRIPTYLINE TABLETS (100) | JAMP PHARMA CORPORATION | 5 Nov 2021 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-AMITRIPTYLINE TABLETS (100) | JAMP PHARMA CORPORATION | 5 Nov 2021 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-AMITRIPTYLINE TABLETS (100) | JAMP PHARMA CORPORATION | 5 Nov 2021 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-AMITRIPTYLINE TABLETS (1000) | JAMP PHARMA CORPORATION | 5 Nov 2021 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-AMITRIPTYLINE TABLETS (100) | JAMP PHARMA CORPORATION | 9 Feb 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-AMITRIPTYLINE TABLETS (1000) | JAMP PHARMA CORPORATION | 9 Feb 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-AMITRIPTYLINE TABLETS (1000) | JAMP PHARMA CORPORATION | 9 Feb 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ELAVIL (100 BTL) | AA PHARMA INC | 29 Nov 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ELAVIL (1000BTL) | AA PHARMA INC | 8 Dec 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ELAVIL (100 BTL) | AA PHARMA INC | 5 Nov 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ELAVIL (1000BTL) | AA PHARMA INC | 5 Nov 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ELAVIL (100 BTL) | AA PHARMA INC | 10 Dec 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-AMITRIPTYLINE (100 BTL) discontinuation | APOTEX INC | not given | not given | Not stated |
| CA | APO-AMITRIPTYLINE (100 BTL) discontinuation | APOTEX INC | not given | not given | Not stated |
| CA | APO-AMITRIPTYLINE (1000 BTL) discontinuation | APOTEX INC | not given | not given | Not stated |
| CA | ELAVIL (1000 BTL) discontinuation | AA PHARMA INC | not given | not given | Not stated |
| CA | ELAVIL (1000 BTL) discontinuation | AA PHARMA INC | not given | not given | Not stated |
| CA | ELAVIL (1000 BTL) discontinuation | AA PHARMA INC | not given | not given | Not stated |
| CA | ELAVIL (100BTL) discontinuation | AA PHARMA INC | not given | not given | Not stated |
| CA | ELAVIL (100BTL) discontinuation | AA PHARMA INC | not given | not given | Not stated |
| CA | ELAVIL (100BTL) discontinuation | AA PHARMA INC | not given | not given | Not stated |
| CA | ELAVIL (100BTL) discontinuation | AA PHARMA INC | not given | not given | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.